Of 14,067,894 reported cancer cases, 280,100 (2%) were attributed to diabetes alone, 544,300 (3.9%) were attributed to a high BMI alone, and 792,600 (5.6%) were attributed to both.
Higher childhood body mass index and increases in BMI during childhood are linked to an increased risk of early adult ischemic stroke.
There is a need for bridging the disconnect between policies that address underweight and overweight children and adolescents.
Obese men have lower semen volume, number, concentration, and motility, as well as a higher prevalence of oligospermia and asthenospermia.
Increases in BMI z-score between 7 and 13 years of age increase a person's risk of ischemic stroke in early adulthood.
Losing weight may result in a decrease of heart muscle thickness.
High costs associated with in vitro fertilization create barriers to fertility treatments that many cannot overcome.
Restricting consumption of high fructose corn syrup did not appear to improve insulin resistance in obese children.
Researchers created a genetic risk score to determine the causal effect of BMI on asthma, hay fever, and allergic sensitization.
Individuals who are considered "overfat" have excess fat, regardless of weight or BMI measurements.
Maternal thyroid function and weight gain in early pregnancy were associated with hypothyroidism, but not hyperthyroidism.
BMI and age at hospital admission are both predictive of potential negative outcomes in patients with anorexia nervosa.
Metformin decreases BMI z score and improves inflammatory parameters in prepubertal children with obesity.
In 2015, more than 107 and 603 million children and adults, respectively, were obese.
Body mass index, waist circumference, and hip circumference were measured to analyze respective associations with increased cancer risks.
Schizophrenia with high BMI is associated with elevated C-reactive protein.
Individuals with low BMI are not at an increased risk for Alzheimer disease.
Patients on HAART may require additional metabolic monitoring for cardiovascular issues.
The optimal body mass index was 23.5 to 27.9 for normoglycemia, 25 to 27.9 for impaired fasting glucose, 25 to 29.4 for newly diagnosed diabetes, and 26.5 to 29.4 for prevalent diabetes.
Patients at maximum BMI in overweight, obese I and obese II categories had an increased risk of all-cause death.
A cross-sectional analysis of participants found that typical BMI criteria may overlook cardiometabolic risk in racial and ethnic minority groups.
Early psychotic symptoms in child or adolescent patients were predictive of elevated BMI and waist circumference scores.
Changes in body weight only partially explain the risk for type 2 diabetes.
Endocrinology Advisor Articles
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Plasma Methylglyoxal Levels Associated With CVD, Mortality in Type 2 Diabetes
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- AMA: Federal Government Must Tackle Rising Insulin Prices
- Diabetes Medication Reconciliation May Reduce Risk of ED Visits